Published on 12/11/2025 12:59 PM
The street is anticipating a weak quarter for Asian Paints due to heavy and extended monsoons, a weak product mix, high competitive intensity, and increased cost of sales.
– Net profit down 16.2% to ₹88 crore from ₹105 crore last year
– Revenue flat at ₹736 crore from ₹733 crore last year
– EBITDA down 14.5% to ₹118.4 crore from ₹138.5 crore last year
– EBITDA margin at 16.1% from 19%
– Stock down 2% after the earnings announcement at ₹307.7
– Thermax shares have extended losses and now trade 5% lower after earnings miss
– PI Industries also extended losses to 5% after management commentary
– Torrent Power shares are down over 3%
– Expect steel realizations to -4.5% qoq on account of seasonal decline in steel prices
– Standalone volumes expected to +17% qoq to 5.6 mt
– Q1 was impacted by the shutdown of blast furnace at Jamshedpur
– India EBITDA/ton will decline to decrease qoq led by lower realizations, partially offset by decrease in coking coal cost
– Revenue likely to grow by 4% from last year to ₹55,934 crore
– EBITDA likely to grow by 38% from last year to ₹8,480 crore
– EBITDA margin may expand to 15.2% from 11.4% last year
– Net profit seen at ₹2,880 crore from ₹759 crore last year
– All numbers as per CNBC-TV18 poll
– Revenue may increase by 1% from last year to ₹8,105 crore
– EBITDA may increase by 7% year-on-year to ₹1,325 crore
– EBITDA margin may expand to 16.3% from 15.4% last year
– Net profit may increase by 25.5% to ₹870 crore
– Numbers are as per a CNBC-TV18 poll
– Indo Count volumes grew by 7% on a sequential basis, while revenue grew by 12%
– Positive traction continues in new businesses
– Net debt to equity stood at 0.34x
– Near term challenges persist, long term growth map intact
– Shares are trading with gains of over 11% at ₹302.5
– Surya Roshni shares are extending losses after gains were reported during market hours on Tuesday.
– The company’s profit nearly doubled, revenue was up 21% and operating performance was also strong
– Margins also expanded 140 basis points from last year
– Yet the stock trades 7.9% lower currently at ₹277.
– Net profit up 57.4% from last year to ₹55.4 crore from ₹35.2 crore
– Revenue up 9.4% from last year to ₹194.4 crore from ₹177.7 crore
– EBITDA up 12.3% year-on-year to ₹60.3 crore from ₹53.7 crore
– EBITDA margin at 31% from 30.2% last year
– Stock surges 7% after results announcement to ₹2,400
– Net profit up 32% from last year to ₹43.3 crore from ₹33 crore
– Revenue up 26.4% year-on-year to ₹184.5 crore from ₹146 crore
– EBITDA up 42% from last year to ₹60 crore from ₹42.3 crore
– EBITDA margin at 32.5% from 29% last year
– Stock jumps to the day’s high, trades 7.5% higher at ₹332.5 after results
– Revenue up 15.7% to ₹1,007.95 crore from ₹871.31 crore last year
– EBITDA up 18% year-on-year to ₹71.24 crore from ₹60.36 crore
– EBITDA margin at 7.1% from 6.9% last year
– Net profit up 56.3% to ₹45.65 crore from ₹29.21 crore
– Gross margin at 25.8% from 23.6% last year
– Stock trades 12% higher at ₹352.4. Shares are up nearly 90% this year
Shares of Kirloskar Oil Engines Ltd. surged as much as 15% on Wednesday, November 12, in response to its September quarter results that were reported after market hours on Tuesday.
Kirloskar Oil reported revenue growth of 34% during the quarter to ₹1,604 crore from ₹1,194 crore during the same quarter last year. Growth was led by the B2B sales, which was aided by the Power Gen and Industrial segments, which grew by 40% from last year.
The international business also continued its strong performance in the Middle East and the North Africa region.
– Execution challenges persist
– Overall margin impact due to adverse product mix and project cost overruns
– Weak margins across Key segments like industrial infra, and chemical
– Order booking is higher due to improved order booking in Industrial Products segment.
– Industrial Infra segment has lower order booking in the current year due to large order bookings in the last year.
– Industrial Products is marginally lower due to product mix
– Profitability is lower in Industrial Infra due to lower margins in projects due to cost overruns
– Stock trading with losses of over 4% on Wednesday
– Net profit up 27% from last year to ₹162.46 from ₹127.51 crore
– Revenue up 30% from last year to ₹1,948.4 crore from ₹1,498.6 crore
– EBITDA up 28.5% to ₹381.75 crore from ₹297.18 crore last year
– EBITDA margin at 19.6% from 19.8% last year
– Stock trades with gains of 13.5% after the results at ₹1,071.85
– Stock is the top gainer on the Nifty 500
– Net profit up 71% from last year to ₹34.7 crore
– Revenue up 42.9% to ₹432.2 crore from ₹302.5 crore last year
– See Strong Tailwinds For Our Business
– See Great Opportunities For Coming Quarters
– Will Hopefully Announce More Activities On The Inorganic Side
– In 5–7 Years, Will Be Achieving $1 Bn In Revenue
– Stock trading with gains of over 5% after the earnings announcement
– Net profit up 56.3% from last year to ₹30 crore
– Revenue up 8% from ₹525.8 crore last year to ₹567.5 crore
– EBITDA up 37% year-on-year to ₹57 crore from ₹41.6 crore
– EBITDA margin expands to 10% from 7.9% last year
– Stock trades 11% higher at ₹98.48. Up 20% so far in 2025
– Net profit down 58.8% to ₹15.9 crore from ₹38.6 crore last year
– Revenue up 25.5% to ₹366.8 crore from ₹292.3 crore last year
– EBITDA at 32.7% from last year to ₹132.3 crore from ₹99.7 crore
– EBITDA margin at 36% from 34.1% last year
– Stock was down as much as 9% in early trading, but is now down 5%
Shares of BSE have jumped 5% in opening trades in response to its Q2 results.
Jefferies has expressed optimism on the stock, while Goldman Sachs remains neutral, although it too, has raised its price target on the stock.
RVNL revenue increased by 5.5% from last year, but its EBITDA, margin and net profit declined from the year-ago period.
Additionally, the state-run company’s operating cash flow also turned negative at the end of the first half of the current financial year.
– Numbers better than expectations
– Growth driven by Generics and biosimilars
– Generics segment growth driven by recently launched products in US & EU such as Liraglutide, generic formulation biz & APIs
– Has commenced filings for Semaglutide in various markets including Canada + Brazil
– Biocon Biologics growth driven by market share expansion and new product launches
– Biosimilar margins expanded for second consecutive quarter with Q2FY26 margins up 400 bps to 25%
– Launched four biosimilars across key global markets so far
– Company is on track for Denosumab biologic launch
– Quarter impacted by Mundra Shutdown & Muted power demand
– Operational weakness offset by Strong Odisha Discom performance & Solar module performance
– On track to Sign Supplementary PPA with Gujarat for Mundra UMPP
– EBITDA down, margins weak
– To set up solar wafers and ingots manufacturing plant with 10 GW capacity
– Turnover data remains strong despite a change in expiry day
– 1st expiry day post day change saw highest-ever daily turnover of ~`50,000 cr
– Q2 average daily notional turnover up 22% QoQ to ₹100 lakh crore
– Operating revenue up 11.5% QoQ
– Transaction charges, largest contributor to BSE’s revenue up 8% QoQ
There are also earnings reactions that the street will be awaiting, such as BSE, which beat consensus expectations supported by strong operating revenue, Tata Power, where results were impacted due to multiple factors.
While the street is awaiting some very important results today, there will also be a reaction to multiple results that were reported after market hours on Tuesday.
More details in subsequent posts.
Good Morning!
Welcome to CNBC-TV18’s Live Coverage of the September quarter results season.
Watch this space for all the live updates.NewsLive TVMarketPopular CategoriesCalculatorsTrending NowLet's Connect with CNBCTV 18Network 18 Group :©TV18 Broadcast Limited. All rights reserved.